CAYMAN CHEMICAL
Bafetinib-10 mg
A Bcr-Abl kinase inhibitor (IC50 = 5.8 nM) that is 25- to 55-fold more potent than imatinib in vitro and &ge10-fold more potent in vivo inhibits 12 out of the 13 most frequent imatinib-resistant Bcr-Abl point mutations, but not the
A Bcr-Abl kinase inhibitor (IC50 = 5.8 nM) that is 25- to 55-fold more potent than imatinib in vitro and &ge10-fold more potent in vivo inhibits 12 out of the 13 most frequent imatinib-resistant Bcr-Abl point mutations, but not the
Specifications
- UPC:
- 51112005
- Condition:
- New
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- Quantity:
- 1
- Unit of Measurement:
- EA
- WeightUOM:
- LB
- MPN:
- 19169-10



